Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
97 Cards in this Set
- Front
- Back
What is used to treat upper GI disease?
|
PPIs (1st line of therapy), antacids, H2 antagonists, prostaglandins, sulcralfate, colloidal bismuth and H. pylori therapy
|
|
what GI symptom is associated with almuinum antacids?
|
constipation
|
|
what about calcium antacids decreases patient compliance?
|
chalky taste
|
|
what GI symptom is associated with magnesium antacids?
|
diarrhea
|
|
which antacids are absorbed slowly and which ones are absorbed quickly?
|
slow - aluminum and magnesium compounds; fast - sodium compoundsa nd clacium compounds;
|
|
What are the adverse effects of aluminum antacids?
|
constipation, intestinal obstruction, osteomalacia
|
|
What are the adverse effects of magnesium antacids?
|
diarrhea, electrolyte abnormalities, dehydration
|
|
what is the first line of therapy for reflux esophagitis?
|
ranitidine
|
|
what is the action of cimetidine on ulcers?
|
accelerates healing and reduces rate or relapse
|
|
what are the adverse effects of cimetidine?
|
anti-androgenic, CNS distrubances, binds to P450, increases blood alcohol levels, may reduce hepatic blood flow, may produce cardiotoxic effects
|
|
how long does cimetidine last?
|
6-8 hours
|
|
is ranitidine more or less potent than cimetidine?
|
more, given at 1/2 the dose; longer effects with fewer adverse effects
|
|
what is cimetidine?
|
H2 angatonist
|
|
What is ranitidine?
|
H2 angatonist
|
|
What is nizatidine?
|
H2 angatonist
|
|
what are the adverse effects of ranitidine?
|
may reduce hepatic flow, headaches, increase blood alcohol levels, may have cardiotoxic effects DOES NOT bind to androgen receptors or elevate prolactin, little effects on drug metabolism and CNS function
|
|
what is omeprazole?
|
PPI
|
|
what is iansoprazole?
|
ppi
|
|
what is pantoprazole?
|
ppi
|
|
what is rabeprazole?
|
ppi
|
|
what is esomeprazole?
|
ppi
|
|
what is the M.O. of ppi's?
|
non-competitive irreversible inhibitor that covalently binds to the proton pump, acts at the final step; it is a lipophilic weak base that diffuse into parietal cell canaliculi where they become protonated and concentrated
|
|
how long does it take ppi's to become effective?
|
3-4 days
|
|
what decreases the bioavilability of ppi's?
|
food - must take ppi 30-60 minutes before eating
|
|
what is the maintanence dose of ppi's?
|
half of the healing dose
|
|
what are the adverse effects of PPI's?
|
infrequent - diarrhea, abdominal pain and headache; increased risk of food poisoning and C. difficil infections; long term use increases cardiac events
|
|
what is misoprostol?
|
PGE1 analog - gastric antisecretory and mucosal protective properties
|
|
what is required to activate sulcralfate?
|
an acidic pH = DON'T give with H2 antagonists!!
|
|
how does sulcralfate aid in healing of ulcers?
|
it polymerizes in the stomach and attachs to injured tissue which forms a protective coat
|
|
how often must sulcralfate be taken?
|
4 times/day
|
|
what are the adverse effects of sulcralfate?
|
constipation - espeically in the elderly; nausea, indigestion, abdominal discomfort, diarrhea, headaches, dizziness, drowsiness
|
|
what does colloidal bismuth do?
|
forms a protective coating on ulcerated tissue, sitmulates mucosal protective mechanisms and has direct antimicrobial effect and sequestration or enterotoxins
|
|
what does colloidal bismuth do to stool?
|
reduces stool frequency and liquidity in infectious diarrhea, turns the stools black
|
|
what is the regimen for H. pylori treatment?
|
at least 2 antibiotics and a PPI - there is a problem with compliance
|
|
what is bethanechol?
|
a muscarinic agonist that is a prokinetic
|
|
what type of motility does bethanechol promote?
|
uncoordinated motility due to stimulation of all muscarinic receptors on the muscle at once
|
|
what is metoclopramide?
|
D2 antagonist that is a prokinetic
|
|
what are the actions of bethanechol?
|
it increases tone of the LES and stimulates gastric acid secretoin
|
|
what is the action of metoclopramide?
|
increases LES tone and esophageal acid clearance; promotes gastric emptying, increases ACh release, no effect on acid or gastrin secrtion, central antiemetic action
|
|
what type of motility does metoclopramide produce?
|
parastaltic - due to stimulation at the ENS
|
|
what are the adverse effects of metoclopramide?
|
drowsiness, extrapyramidal effects; chronic use can cause parkinsonism, other extrapyramidal effects and hyperprolactinemia
|
|
what is domperidone?
|
D2 antagonist that is peripherally restricted that is a prokinetic
|
|
what is cisapride?
|
prpkinetic
|
|
what is the action of cisapride?
|
increases gastric emptying
|
|
what is the M.O. of cisapride?
|
5HT4 agonist = prokinetic and some 5HT3 antagonist acitivty; works at the level of the ENS to cause post-ganglionic release of ACh
|
|
what are the side effects of cisapride?
|
ventricular arrhythmias - potentially fatal
|
|
what is tegaserod?
|
a peripherally restricted prokinetic
|
|
when is tegaserod used?
|
restricted use for women >55 yoa with constipation IBS and for chronic constipation
|
|
what is the M.O. of tegaserod?
|
5HT4 agonist and 5HT2b antagonist - causes side effects; augments intestinal peristalsis; NO CNS activity
|
|
what are the toxicities of tegaserod?
|
CV - increased stroke, unstable angina and heart attacks
|
|
what is erythromycin?
|
prokinetic
|
|
what is the M.O. of erythromycin?
|
motilin agonist, increases LES tone, sppeds up upper GI transit, efficacy best with IV
|
|
when is erythromycin used?
|
in diabetic gastroparesis to enhance gastric emptying
|
|
what are the side effects of erythromycin?
|
abdominal cramping and diarrhea, liver toxicity
|
|
what are the 6 stimulant laxatives?
|
castor oil, cascara, senna, phenolphalein, bisacodyl, magnesium hydroxide
|
|
what is the action of senna and cascara
|
they are anthrquinones that stimulate ENS to increase motility
|
|
what is the action of phenolphalein and bisacodyl?
|
diphenylmethane derivates that stimulate water and electrolyte accumulation and enchance colonic motility
|
|
what are the 5 dietary and bulk forming laxatives?
|
bran, lactulose, sorbitol, pysllium, metamucil
|
|
what is the action of bulk forming laxatives?
|
bind water and ions int eh colonic lumen, softens feces, increases fecal mass and increases rate of colonic transit - effects occur in 24 hours
|
|
what are the adverse effects of bulk forming laxatives?
|
faltulence, borborygmi, reduced intestinal absorption of drugs, intestinal obstruciton/impaction, abdominal distension
|
|
what are the 5 lubricating laxatives?
|
magnesium salts, lactulose, glycerin, mineral oil, sorbitol
|
|
what is the M.O. of lubricating laxatives?
|
they are poorly absorbed, osmotic properties retain water in the intestinal lumen
|
|
what are lubricating laxatives used for?
|
bowel prep prior to surgery
|
|
what are the adverse effects of lubricating laxatives?
|
lactulose: cramping flatuelnce, discomfort; Mg: effects on renal funciton; phosphate: severe effects on kidneys; PEG: fewer cramps
|
|
what are the 3 stool softeners/
|
mineral oil, glycerin, docusate
|
|
what is lubiprostone?
|
PGE1 metabolite that is a chloride channel activator that is used to treat constipation
|
|
what is lubiprostone used for?
|
chronic idiopathic constipation
|
|
what are the side effects of lubiprostone?
|
nausea and diarrhea
|
|
what is methylnaltrexone?
|
peripherally restricted mu opioid antagonist
|
|
when is methylnaltrexone used?
|
in opioid induced bowel dysfunciton
|
|
what are the side effects of methylnaltrexone?
|
abdominal pain and flatuence BUT NO symptoms of opioid withdrawal
|
|
what is alvimopan?
|
peripherally restricted mu opioid antagonist
|
|
when is alvimopan used?
|
to treat post operative ilius
|
|
what is the adverse effect of alvimopan?
|
high number of Mis reported
|
|
what is loperamide?
|
opioid agonist used to treat diarrhea
|
|
when should loperamide not be used?
|
contraindicated in IBD - will lead to toxic megacolon
|
|
what is diphenoxylate?
|
opioid agonist used to treat diarrhea
|
|
when is diphenoxylate used?
|
for travelers diarrhea
|
|
what is clonidine?
|
sympathetic agonist used to treat diarrhea
|
|
when is clonidine used?
|
in patients refractory to everything else
|
|
where does clonidine act?
|
at both the neuron to inhibit release of secretory NT and at the epithelial alpha 2 recetpors to stimulate absorption
|
|
what is budesonide?
|
a corticosteroid used to treat IBD - low systemic bioavilability
|
|
what is sulfasalasine?
|
a IBD drug used to treat mild disease and for the maintance of remssion
|
|
what are the side effects of sulfasalasine?
|
dyspepsia, nausea, anorexia, headache, allergic reactions, mild to severe hymolysis, neutropenia, folate deficiency, male infertility
|
|
where can severe toxic reactions to sulfasalasine occur?
|
lung, liver, pancreas, skin or nerves
|
|
what is olsalazine?
|
5ASA derivative, a dimer; used to treat IBD
|
|
what is balsaladie?
|
5ASA derivative, an inert carrier; used to treat IBD
|
|
what is pentasa?
|
mesalamine (5ASA derivative) used to treat IBD in the small intestine
|
|
what is asacol?
|
mesalamine (5ASA derivative) used to treat IBD in the distal ileum/proximal colon
|
|
what is rowasa?
|
mesalamine (5ASA derivative) used to treat IBD in the rectum
|
|
what is infliximab?
|
anti-TNF alpha therapy used to treat IBD
|
|
what is certolizumab?
|
anti-TNF alpha therapy used to treat IBD
|
|
What is natalizumab and adalimumab?
|
anti-TNF alpha therapy used to treat IBD
|
|
what are the side effects of infliximab?
|
lymphoma esepcially in children, sereious infection - sepsis, TB, histo
|
|
what is used to treat IBS?
|
anticholinergics, alosteron (diarrhea IBS) and teraserod (constipation IBS)
|
|
what is used to treat motion sickness?
|
scopolamine (anticholinergic) and H1 antihistamines - diphenhydramine and meclizine
|
|
what is used to treat chemo induced vomiting?
|
5HT3 antagonists: ondansetron, granisteron and dolasteron; dopamine antagonists: metoclopramide, doperidone; cannabinoids
|